The estimated Net Worth of Azadeh Golipour is at least 95.3 千$ dollars as of 1 February 2024. Ms Golipour owns over 37,334 units of AvroBio Inc stock worth over 95,346$ and over the last 2 years she sold AVRO stock worth over 0$.
Ms has made over 1 trades of the AvroBio Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she exercised 37,334 units of AVRO stock worth 52,268$ on 1 February 2024.
The largest trade she's ever made was exercising 37,334 units of AvroBio Inc stock on 1 February 2024 worth over 52,268$. On average, Ms trades about 9,334 units every 0 days since 2022. As of 1 February 2024 she still owns at least 68,104 units of AvroBio Inc stock.
You can see the complete history of Ms Golipour stock trades at the bottom of the page.
Azadeh Golipour Ph.D. is the Chief Technology Officer at AvroBio Inc.
Azadeh's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.
Over the last 6 years, insiders at AvroBio Inc have traded over 3,066,308$ worth of AvroBio Inc stock and bought 2,395,057 units worth 31,037,133$ . The most active insiders traders include Braden Michael Leonard、Bruce Booth、Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of 206,675$. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth 973,626$.
clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.
AvroBio Inc executives and other stock owners filed with the SEC include: